Organized by the Office of the High Commissioner for Human Rights with the support of Canada, Ghana, Switzerland, the United Kingdom, and the Commission of Human Rights of the Philippines, the European Union, Harm Reduction International, the International Centre on Human Rights and Drug Policy, the International Drug Policy Consortium, the International Network of People …
European Union
Plenary Item 7. Inter-agency cooperation and coordination of efforts in addressing and countering the world drug problem
Working Group on Arbitrary Detention, United Nations Human Rights Council: It is my honor to address the United Nations Commission on Narcotic Drugs to present the study on arbitrary detention relating to drug policies prepared by the UN Working Group on Arbitrary Detention at the request of the Human Rights Council and presented to the …
Plenary Item 7. Inter-agency cooperation and coordination of efforts in addressing and countering the world drug problem
CHAIR: Introduction to Item 7 UNODC: We have produced a communication package to UN countries to help them see how the UN system can better support implementation of drug policy. This package includes relevant guidelines and considerations. We hope to report even more progress next year. UNODC: (…) drug prevention, treatment and care based on scientific …
Plenary Item 5. Implementation of the international drug control treaties (continued) (Night Session)
Item 5 (d). International cooperation to ensure the availability of narcotic drugs and psychotropic substances for medical and scientific purposes while preventing their diversion CHAIR: Introduction to Item 5d. We offer the framework to scale and improve the availability of narcotic drugs and psychotropic substances for medical and scientific purposes. This issue is very important to my home …
Committee of the Whole. L.7. Intensifying efforts to address the proliferation of uncontrolled and designer precursors used in the illicit manufacture of drugs
OP8 Alt & bis United States: We started from the title in informals. We haven’t discussed certain OPs. I don’t believe OP8 Alt & Bis are in a position to be finalised. OP8 is dealing with legislative measures to address the problem of designer precursor chemicals. So it’s a sensitive issue because it’s domestic legislation. …
Side event: Leaving no one behind: the rights-based and development-oriented approach of the European Union to drug policies in cooperation initiatives in Central Asia, Latin America and the Caribbean
Organized by Spain with the support of Germany, Paraguay, and the European Union and the European Union Delegation to Kyrgyzstan Joan R. Villalbí. Government Delegate for the National Plan on Drugs. Ministry of Health. Spain: Opening remarks. Merle Kreibaum. Senior Policy Officer. Federal Ministry for Economic Cooperation and Development (BMZ). Germany: In 2020, under the …